SAN FRANCISCO, June 16, 2025 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) will host a webcast and conference call with senior management to discuss its second quarter results, current market conditions and future outlook on Wednesday, July 16, 2025, at 9:00 a.m. PT/12:00 p.m. ET.To access a live broadcast of the call, please dial +1 (877) 897-2615 (toll-free from the United States and Canada) or +1 (201) 689-8514 (from all other countries). A live webcast can be accessed from the Investor Relations section of ...

BOISE, Idaho, June 16, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that it has closed its previously announced upsized US$325 million public offering of 24,622,000 common shares, no par value, of the Company (the "Common Shares") at a price of US$13.20 per Common Share (the "Offering"). Concurrently with the closing of the Offering, the Company closed its US$100 million private placement of 7,575,757 Common Sha ...

Group 1 - Banco Comercial Português, S.A. has announced the issuance of senior preferred debt securities that are eligible for Minimum Requirement for Own Funds and Eligible Liabilities (MREL) [1] - The issuance is part of the bank's strategy to strengthen its capital structure and meet regulatory requirements [1] - The specific details regarding the amount and terms of the debt securities have not been disclosed in the announcement [1]

Core Points - Decade Resources Ltd. has successfully closed an oversubscribed flow-through private placement, raising total gross proceeds of $308,500 [1][2]. Group 1: Financial Details - A total of 8,814,286 flow-through units were issued at a price of 3.5 cents per unit, which includes one flow-through common share and one transferable non-flow-through common share purchase warrant [2]. - Each warrant is exercisable for the purchase of one additional common share at a price of $0.05 per share for a period of 24 months [2]. Group 2: Use of Proceeds - Proceeds from the sale will be used for incurring flow-through expenses that qualify as Canadian exploration expenses and flow-through critical mineral mining expenditures as defined in the Income Tax Act (Canada) [3]. - The funds will specifically be allocated to the Company's properties in British Columbia [3]. Group 3: Additional Information - The company paid cash finder's fees totaling $16,200 and issued 462,857 warrants at $0.05 to the finders, with the warrants also being exercisable for a 24-month period [4]. - All issued securities are subject to a statutory hold period of four months, expiring on October 14, 2025 [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 1, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible to join a class action lawsuit [1][2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to represent other class members [2][6]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Allegations Against Fortrea - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue projections and cost savings, leading to inflated EBITDA targets for 2025 [4]. - The claims suggest that Fortrea's business model and financial prospects were overstated, resulting in investor damages when the true information became public [4].

Core Insights - Moderna is focusing on its oncology pipeline as a key area of interest for investors moving forward [3][4]. Company Overview - The conference call is part of Barclays' 8th annual speaking science conference series, aimed at discussing scientific concepts, clinical program progress, and company strategy [1][2]. Oncology Pipeline - Rose Loughlin, EVP of Research, is presenting a comprehensive slide deck regarding Moderna's oncology pipeline, indicating its importance in the company's future development [3][5]. - The oncology space is highlighted as a significant focus for Moderna, with expectations of substantial investor interest [3].

Visit www.OpportunityAtOportun.com to Download the PresentationNEW YORK, June 16, 2025 /PRNewswire/ -- Findell Capital Partners, LP, (together with its affiliates, "Findell," "we" or "us") one of the largest stockholders of Oportun Financial Corporation (NASDAQ: OPRT) ("Oportun" or the "Company"), today released an investor presentation highlighting the urgent need for additional independence and consumer finance industry expertise in the Company's boardroom.In the presentation, Findell outlines what it see ...

Core Viewpoint - FibroBiologics, Inc. has successfully closed the third $5 million tranche of a Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors, allowing the company to raise up to $25 million over two years for its therapeutic development efforts [1][2]. Financing Details - The SEPA allows FibroBiologics to sell up to $25 million in common stock to Yorkville over two years, with the first three tranches totaling $15 million being advanced in equal parts of $5 million each [2]. - The third tranche of $5 million was funded after the effectiveness of a registration statement and shareholder approval, complying with Nasdaq rules [2]. Use of Proceeds - The net proceeds from this financing are intended for general corporate purposes, including funding research and development programs and supporting an upcoming Phase 1/2 clinical trial for diabetic foot ulcers expected to start in the second half of 2025 [3]. Company Overview - FibroBiologics is a clinical-stage biotechnology company based in Houston, focusing on developing therapeutics and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials [7][8]. - The company holds over 275 patents issued and pending, covering various clinical pathways such as wound healing, multiple sclerosis, and cancer [8].

Core Insights - Coherent Corp. has expanded its PowerMax™ sensor portfolio with the introduction of the PM15K+ high-power laser sensor and a backscatter shield for the PM10K+, addressing the increasing demand for precise and safe high-power laser measurements in industrial settings [1][4] Group 1: Product Innovations - The PM15K+ sensor can measure continuous laser power up to 15 kW and intermittent power up to 20 kW, featuring a large active area of 100 mm x 100 mm, suitable for high-power diode and fiber laser systems [2] - The PM15K+ sensor has a response time of 5 seconds, making it ideal for high-throughput industrial applications requiring quick and reliable measurements [2] - The new backscatter shield for the PM10K+ sensor significantly enhances measurement accuracy by reducing reflected laser energy from 10-15% to 1% or less, thus improving safety for surrounding equipment and personnel [3] Group 2: Market Applications - Both the PM15K+ and the enhanced PM10K+ are compatible with Coherent's LabMax-Pro and PowerMax-Pro systems, supporting a variety of applications in industrial manufacturing, scientific research, and medical laser fields [4]

Core Insights - Shoals Technologies Group, Inc. has appointed Bobbie L. King, Jr. as Chief Legal Officer and Corporate Secretary to enhance its legal strategy and support sustainable growth [1][2][3] Company Overview - Shoals Technologies Group is a leading provider of electrical balance of system solutions and components for the global energy transition market, including battery energy storage solutions [4] - The company has been recognized for its innovative technologies that improve installation efficiency, safety, and system performance since its founding in 1996 [4] Executive Team Enhancement - Bobbie L. King, Jr. brings over 15 years of legal and leadership experience in the clean infrastructure industry, previously serving at HA Sustainable Infrastructure Capital, Inc. and holding senior roles at NextEra Energy, Inc. and Charles River Laboratories [2][3] - The CEO of Shoals, Brandon Moss, expressed confidence in Mr. King's ability to drive operational efficiencies and support growth within the company [3]